☰ Navigation Tabs
Influenza Haemagglutinin fusion peptide mutant G13A
NMR Experiment Experiment Type Sample Contents Solvent Ionic Strength pH Pressure Temperature (K) Spectrometer 1 2D 1H-1H TOCSY 2 mM [U-15N] Influenza HA fusion peptide G13A, 200 mM [U-2H] DPC, 20 mM [U-2H] acetic acid, 5 mM DTT 95% H2O/5% D2O 5 ambient 303 2 2D 1H-1H NOESY 2 mM [U-15N] Influenza HA fusion peptide G13A, 200 mM [U-2H] DPC, 20 mM [U-2H] acetic acid, 5 mM DTT 95% H2O/5% D2O 5 ambient 303 3 3D HNHA 1 mM [U-15N] Influenza HA fusion peptide G13A, 200 mM [U-2H] DPC 20 mM [U-2H] acetic acid, 5 mM DTT 95% H2O/5% D2O 5 ambient 303 4 3D 1H-15N NOESY 1 mM [U-15N] Influenza HA fusion peptide G13A, 200 mM [U-2H] DPC 20 mM [U-2H] acetic acid, 5 mM DTT 95% H2O/5% D2O 5 ambient 303
NMR Spectrometer Information Spectrometer Manufacturer Model Field Strength 1 Varian INOVA 600
NMR Refinement Method Details Software simulated annealing Sparky
NMR Ensemble Information Conformer Selection Criteria structures with the lowest energy Conformers Calculated Total Number 40 Conformers Submitted Total Number 20 Representative Model 1 (closest to the average)
Computation: NMR Software # Classification Version Software Name Author 1 chemical shift assignment Sparky Goddard 2 data analysis Sparky Goddard 3 processing NMRPipe Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax 4 refinement OPAL Luginbuhl, Guntert, Billeter and Wuthrich 5 structure solution CYANA Guntert, Mumenthaler and Wuthrich